ChineseChina UKUK DeutschlandDeutschland FranceFrance РоссияРоссия 한국한국 ไทยไทย Việt NamViệt Nam العربيةالعربية ҚазақстанҚазақстан EspañaEspaña MyanmarMyanmar DaiDai

Linking China’s Premium Healthcare · Serving Global Health Needs

Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties

One-Stop Medical Care in China

  • International flights · Airport pickup · Nearby hotels
  • Multilingual interpreters · Full medical escort
  • Expert matching · Hospital fast-track
  • Full-cycle treatment · Post-op follow-up
Sign in

Dr. David: Transplantation of blood stem cells

Patient basic information Patient: Mr. David Clark) Nationality: South Korea Disease diagnosis: blood stem cell transplantation Clinical hospital: H0ZH Treatment Plan: Micro-lesion surgery + postoperative rehabilitation Household days: 119 days Treatment cost: about 1110391 yuan Treatment effect: partial relief The patient describes Mr. David from South Korea, who was diagnosed locally as a blood stem cell transplant.

Upon arrival, the International Medical Services Team arranged for the first time multidisciplinary MDT for patients, developed individualized clinical pathways based on the patient's examination reports and physical condition, and provided translation, assistance and on-site services throughout the treatment process. After 119 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas, reaching the hospital standard. The treatment effect was finally partially alleviated.

When the patient left the hospital, the medical team developed a detailed return follow-up and rehabilitation plan for him and continued to track the recovery through a remote follow-up system. The patient said 'We are impressed with the level of expertise of Chinese doctors and the condition of the equipment at Chinese hospitals, with a well-equipped line at every link from the ground to the hospital. 'Mr.

Liu David has criticized the case as a typical case of cross-border suspected serious clinical disease. Liu4 is a multidisciplinary collaborative mechanism that develops microscopic surgery + post-operative rehabilitation for stem cell transplantation, reflecting the comprehensive strength of Chinese hospitals in the field of suspected diagnostics and a summary of how international medical services are regulated. (Figure from Liu5 official news reports and medical scenarios)

韩国,造血干细胞移植,吉林大学第一医院,国际医疗,来华就医,中国医疗